Precision Medicine in the Treatment of Primary Immune Deficiency Patients With Disorders of Immune Dysregulation
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology and Allergy
Link
https://link.springer.com/content/pdf/10.1007/s12016-021-08871-4.pdf
Reference31 articles.
1. Tangye SG, Al-Herz W, Bousfiha A et al (2020) Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol 40:24–64
2. Leiding JW, Ballow M (2018) Precision medicine in the treatment of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol 18:159–166
3. Leiding JW, Forbes LR (2019) Mechanism-based precision therapy for the treatment of primary immunodeficiency and primary immunodysregulatory diseases. J Allergy Clin Immunol Pract 7:761–773
4. Tangye SG, Al-Herz W, Bousfiha A et al (2021) The ever-increasing array of novel inborn errors of immunity: an interim update by the IUIS Committee. J Clin Immunol 41:666–679
5. Notarangelo LD, Bacchetta R, Casanova JL, Su HC (2020) Human inborn errors of immunity: an expanding universe. Sci Immunol 5
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital Immunodeficiencies;The Journal of Allergy and Clinical Immunology: In Practice;2023-11
2. Future Directions in the Diagnosis and Treatment of APDS and IEI: a Survey of German IEI Centers;Frontiers in Immunology;2023-10-05
3. Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens;Journal of Clinical Immunology;2023-05-09
4. Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience With Enhanced Infusion Regimens;2023-03-24
5. Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders;Frontiers in Molecular Neuroscience;2022-07-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3